{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T18:16:03Z","timestamp":1768414563986,"version":"3.49.0"},"reference-count":108,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.ncl.2018.09.009","type":"journal-article","created":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T11:14:33Z","timestamp":1542798873000},"page":"63-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Pituitary Disorders in Pregnancy"],"prefix":"10.1016","volume":"37","author":[{"given":"Whitney W.","family":"Woodmansee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ncl.2018.09.009_bib1","first-page":"64","article-title":"Pituitary dimensions and volume measurements in pregnancy and post-partum. MR assessment","volume":"39","author":"Dinc","year":"1998","journal-title":"Acta Radiol"},{"issue":"7","key":"10.1016\/j.ncl.2018.09.009_bib2","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00417-006-0491-3","article-title":"Loss of vision due to a physiologic pituitary enlargement during normal pregnancy","volume":"245","author":"Inoue","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"10.1016\/j.ncl.2018.09.009_bib3","doi-asserted-by":"crossref","first-page":"589","DOI":"10.4158\/EP13341.RA","article-title":"Thyroid physiology in pregnancy","volume":"20","author":"Moleti","year":"2014","journal-title":"Endocr Pract"},{"key":"10.1016\/j.ncl.2018.09.009_bib4","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1210\/er.2004-0025","article-title":"The hypothalamic\u2013pituitary\u2013adrenal axis in pregnancy: challenges in disease detection and treatment","volume":"26","author":"Lindsay","year":"2005","journal-title":"Endocr Rev"},{"issue":"3","key":"10.1016\/j.ncl.2018.09.009_bib5","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1530\/EJE-09-0923","article-title":"Pregnancy and pituitary disorders","volume":"162","author":"Karaca","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.ncl.2018.09.009_bib6","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1210\/jc.2002-020787","article-title":"A\u00a0new nonisotopic, highly sensitive assay for the measurement of human placental growth hormone: development and clinical implications","volume":"88","author":"Wu","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ncl.2018.09.009_bib7","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/cncr.20412","article-title":"The prevalence of pituitary adenomas: a systematic review","volume":"101","author":"Ezzat","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.ncl.2018.09.009_bib8","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11060-013-1354-5","article-title":"Epidemiology and etiopathogenesis of pituitary adenomas","volume":"117","author":"Aflorei","year":"2014","journal-title":"J\u00a0Neurooncol"},{"issue":"suppl 5","key":"10.1016\/j.ncl.2018.09.009_bib9","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/now207","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2009-2013","volume":"18","author":"Ostrom","year":"2016","journal-title":"Neuro Oncol"},{"issue":"2","key":"10.1016\/j.ncl.2018.09.009_bib10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ando.2012.03.039","article-title":"Prevalence and incidence of pituitary adenomas","volume":"73","author":"Karavitaki","year":"2012","journal-title":"Ann Endocrinol (Paris)"},{"issue":"1","key":"10.1016\/j.ncl.2018.09.009_bib11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11102-010-0253-4","article-title":"Demographic differences in incidence for pituitary adenoma","volume":"14","author":"McDowell","year":"2011","journal-title":"Pituitary"},{"issue":"4","key":"10.1016\/j.ncl.2018.09.009_bib12","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1210\/jc.2010-1048","article-title":"Pituitary incidentaloma: an endocrine society clinical practice guideline","volume":"96","author":"Freda","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ncl.2018.09.009_bib13","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2265.2006.02562.x","article-title":"Guidelines of the pituitary society for the diagnosis and management of prolactinomas","volume":"65","author":"Casaneuva","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.ncl.2018.09.009_bib14","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2265.2009.03667.x","article-title":"Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK)","volume":"72","author":"Fernandez","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"10.1016\/j.ncl.2018.09.009_bib15","doi-asserted-by":"crossref","first-page":"832","DOI":"10.4158\/EP14541.DSCR","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology Disease state clinical review: postoperative management following pituitary surgery","volume":"21","author":"Woodmansee","year":"2015","journal-title":"Endocr Pract"},{"issue":"9","key":"10.1016\/j.ncl.2018.09.009_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0011-5029(82)90628-9","article-title":"Hyperprolactinemic disorders","volume":"28","author":"Molitch","year":"1982","journal-title":"Dis Mon"},{"issue":"3","key":"10.1016\/j.ncl.2018.09.009_bib17","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.fertnstert.2009.12.017","article-title":"Prevalence of hyperprolactinemia and abnormal magnetic resonance imaging findings in a population with infertility","volume":"94","author":"Souter","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ncl.2018.09.009_bib18","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1056\/NEJMcp0912025","article-title":"Prolactinomas","volume":"362","author":"Klibanski","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.ncl.2018.09.009_bib19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/jc.2010-1692","article-title":"Diagnosis and treatment of hyperprolactinemia: an endocrine society clinical practice guideline","volume":"96","author":"Melmed","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ncl.2018.09.009_bib20","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.jocn.2015.03.059","article-title":"Update on prolactinomas. Part 2: treatment and management strategies","volume":"22","author":"Wong","year":"2015","journal-title":"J\u00a0Clin Neurosci"},{"key":"10.1016\/j.ncl.2018.09.009_bib21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11102-005-5085-2","article-title":"Pharmacologic resistance in prolactinoma patients","volume":"8","author":"Molitch","year":"2005","journal-title":"Pituitary"},{"key":"10.1016\/j.ncl.2018.09.009_bib22","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.jocn.2015.06.001","article-title":"Current indications for the surgical treatment of prolactinomas","volume":"22","author":"Smith","year":"2015","journal-title":"J\u00a0Clin Neurosci"},{"issue":"2","key":"10.1016\/j.ncl.2018.09.009_bib23","doi-asserted-by":"crossref","first-page":"236","DOI":"10.20945\/2359-3997000000032","article-title":"Controversial issues in the management of hyperprolactinemia and prolactinomas - An overview by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism","volume":"62","author":"Vilar","year":"2018","journal-title":"Arch Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ncl.2018.09.009_bib24","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.beem.2011.05.011","article-title":"Prolactinoma in pregnancy","volume":"25","author":"Molitch","year":"2011","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ncl.2018.09.009_bib25","doi-asserted-by":"crossref","first-page":"R205","DOI":"10.1530\/EJE-14-0848","article-title":"Endocrinology in pregnancy: management of the pregnant patient with a prolactinoma","volume":"172","author":"Molitch","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ncl.2018.09.009_bib26","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000180100","article-title":"Follow-up of children born of bromocriptine-treated mothers","volume":"22","author":"Raymond","year":"1985","journal-title":"Horm Res"},{"issue":"2","key":"10.1016\/j.ncl.2018.09.009_bib27","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2265.2010.03808.x","article-title":"Outcome of 100 pregnancies initiated under treatment with cabergoline in hyperprolactinaemic women","volume":"73","author":"Lebbe","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"10.1016\/j.ncl.2018.09.009_bib28","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11102-010-0243-6","article-title":"Effects of cabergoline on pregnancy and embryo-fetal development: retrospective study on 103 pregnancies and a review of the literature","volume":"13","author":"Stalldecker","year":"2010","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.ncl.2018.09.009_bib29","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s12020-014-0334-7","article-title":"Prolactinomas, cabergoline and pregnancy","volume":"47","author":"Glezer","year":"2014","journal-title":"Endocrine"},{"issue":"10","key":"10.1016\/j.ncl.2018.09.009_bib30","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1055\/s-0043-112861","article-title":"Pregnancy and tumor outcomes in women with prolactinoma","volume":"125","author":"Arauju","year":"2017","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"4","key":"10.1016\/j.ncl.2018.09.009_bib31","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1080\/09513590.2016.1254177","article-title":"Pregnancy and tumor outcomes in infertile women with macroprolactinoma on cabergoline therapy","volume":"33","author":"Rastogi","year":"2017","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"10.1016\/j.ncl.2018.09.009_bib32","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ando.2016.04.001","article-title":"Prolactinoma and pregnancy: from the wish of conception to lactation","volume":"77","author":"Maiter","year":"2016","journal-title":"Ann Endocrinol (Paris)"},{"issue":"1","key":"10.1016\/j.ncl.2018.09.009_bib33","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/AOG.0000000000001747","article-title":"Macroprolactinomas and nonfunctioning pituitary adenomas and pregnancy outcomes","volume":"129","author":"Lambert","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ncl.2018.09.009_bib34","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0028-2243(92)90094-F","article-title":"Long-term effects of time, medical treatment and pregnancy in 176 hyperprolactinemic women","volume":"44","author":"Crosignani","year":"1992","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"10.1016\/j.ncl.2018.09.009_bib35","first-page":"306","article-title":"The long-term effects of pregnancy and bromocriptine treatment on prolactinomas--the value of radiologic studies","volume":"3","author":"Badawy","year":"1997","journal-title":"Early Pregnancy"},{"issue":"5","key":"10.1016\/j.ncl.2018.09.009_bib36","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/cen.12370","article-title":"Outcome of prolactinoma after pregnancy and lactation: a study on 73 patients","volume":"80","author":"Domingue","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"10.1016\/j.ncl.2018.09.009_bib37","first-page":"2730","article-title":"Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group","volume":"83","author":"Orme","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ncl.2018.09.009_bib38","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1530\/EJE-08-0267","article-title":"A\u00a0meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly","volume":"159","author":"Holdaway","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ncl.2018.09.009_bib39","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1210\/jc.2007-1191","article-title":"Mortality in acromegaly: a meta-analysis","volume":"93","author":"Dekkers","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.ncl.2018.09.009_bib40","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1210\/jc.2014-2700","article-title":"Acromegaly: an endocrine society clinical practice guideline","volume":"99","author":"Katznelson","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.ncl.2018.09.009_bib41","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/s41574-018-0058-5","article-title":"A\u00a0consensus statement on acromegaly therapeutic outcomes","volume":"14","author":"Melmed","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"10.1016\/j.ncl.2018.09.009_bib42","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/EJE-16-1059","article-title":"Management of endocrine disease: acromegaly and pregnancy: a contemporary review","volume":"177","author":"Abucham","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"10.1016\/j.ncl.2018.09.009_bib43","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1210\/jc.2009-2331","article-title":"Acromegaly and pregnancy: a retrospective multicenter study of 59 pregnancies in 46 women","volume":"95","author":"Caron","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ncl.2018.09.009_bib44","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1365-2265.2011.04180.x","article-title":"Pregnancy in acromegaly: experience from two referral centers and systematic review of the literature","volume":"76","author":"Cheng","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.ncl.2018.09.009_bib45","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11102-011-0330-3","article-title":"Pregnancy and acromegaly: a review","volume":"15","author":"Cheng","year":"2012","journal-title":"Pituitary"},{"key":"10.1016\/j.ncl.2018.09.009_bib46","unstructured":"Somatuline Depot (lanreotide) [package insert]. Signes, France: Ipsen Pharma Biotech; 2014."},{"key":"10.1016\/j.ncl.2018.09.009_bib47","unstructured":"Signifor (pasireotide) [package insert]. Stein, Switzerland: Novartis Pharma Stein AG; 2012."},{"issue":"3","key":"10.1016\/j.ncl.2018.09.009_bib48","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s12020-014-0508-3","article-title":"Pregnancy in acromegaly patients treated with pegvisomant","volume":"49","author":"van der Lely","year":"2015","journal-title":"Endocrine"},{"issue":"5","key":"10.1016\/j.ncl.2018.09.009_bib49","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing\u2019s syndrome: an endocrine society clinical practice guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ncl.2018.09.009_bib50","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1210\/er.2013-1048","article-title":"The treatment of Cushing\u2019s disease","volume":"36","author":"Pivonello","year":"2015","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ncl.2018.09.009_bib51","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s11102-015-0645-6","article-title":"Comorbidities in Cushing\u2019s disease","volume":"18","author":"Sharma","year":"2015","journal-title":"Pituitary"},{"key":"10.1016\/j.ncl.2018.09.009_bib52","doi-asserted-by":"crossref","first-page":"M11","DOI":"10.1530\/EJE-15-0198","article-title":"Adverse effects of glucocorticoids: coagulopathy","volume":"173","author":"Coelho","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.ncl.2018.09.009_bib53","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11102-015-0640-y","article-title":"Quality of life in Cushing\u2019s syndrome","volume":"18","author":"Santos","year":"2015","journal-title":"Pituitary"},{"issue":"2","key":"10.1016\/j.ncl.2018.09.009_bib54","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1210\/jc.2009-0806","article-title":"Metabolic, cardiovascular, and cerebrovascular outcomes in growth hormone-deficient subjects with previous Cushing\u2019s disease or non-functioning pituitary adenoma","volume":"95","author":"Webb","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ncl.2018.09.009_bib55","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1210\/jc.2006-2112","article-title":"Mortality in patients treated for Cushing's disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma","volume":"92","author":"Dekkers","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ncl.2018.09.009_bib56","doi-asserted-by":"crossref","first-page":"R143","DOI":"10.1530\/EJE-14-0556","article-title":"Management of endocrine disease: mortality remains increased in Cushing\u2019s disease despite biochemical remission: a systematic review and meta-analysis","volume":"172","author":"Van Haalen","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"15","key":"10.1016\/j.ncl.2018.09.009_bib57","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMra1505550","article-title":"Diagnosis and differential diagnosis of Cushing\u2019s syndrome","volume":"376","author":"Loriaux","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ncl.2018.09.009_bib58","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/MED.0b013e3283631809","article-title":"Update in the medical therapy of Cushing\u2019s disease","volume":"20","author":"Nieman","year":"2013","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"8","key":"10.1016\/j.ncl.2018.09.009_bib59","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1210\/jc.2015-1818","article-title":"Treatment of Cushing\u2019s syndrome: an endocrine society clinical practice guideline","volume":"100","author":"Nieman","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ncl.2018.09.009_bib60","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1227\/01.NEU.0000313117.35824.9F","article-title":"Outcomes after repeat transsphenoidal surgery for recurrent Cushing's disease","volume":"63","author":"Patil","year":"2008","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ncl.2018.09.009_bib61","doi-asserted-by":"crossref","first-page":"R85","DOI":"10.1530\/EJE-14-1130","article-title":"Management of endocrine disease. Management of pregnancy patients with Cushing\u2019s syndrome","volume":"173","author":"Bronstein","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ncl.2018.09.009_bib62","doi-asserted-by":"crossref","first-page":"R259","DOI":"10.1530\/EJE-17-1058","article-title":"Management of endocrine disease. Management of Cushing\u2019s syndrome during pregnancy: solved and unsolved questions","volume":"178","author":"Brue","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ncl.2018.09.009_bib63","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11102-015-0680-3","article-title":"Determination of nighttime salivary cortisol during pregnancy: comparison with values in non-pregnancy and Cushing\u2019s disease","volume":"19","author":"Lopes","year":"2016","journal-title":"Pituitary"},{"key":"10.1016\/j.ncl.2018.09.009_bib64","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1210\/jc.2004-2361","article-title":"Cushing\u2019s syndrome during pregnancy: personal experience and review of the literature","volume":"90","author":"Lindsay","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ncl.2018.09.009_bib65","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s12020-016-1117-0","article-title":"Cushing\u2019s syndrome and pregnancy outcomes: a systematic review of published cases","volume":"55","author":"Caimari","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.ncl.2018.09.009_bib66","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/MED.0000000000000331","article-title":"Update on adrenal insufficiency: diagnosis and management in pregnancy","volume":"24","author":"Langlois","year":"2017","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"3","key":"10.1016\/j.ncl.2018.09.009_bib67","doi-asserted-by":"crossref","first-page":"453","DOI":"10.14310\/horm.2002.1685","article-title":"Cabergoline treatment for recurrent Cushing's disease during pregnancy","volume":"15","author":"Nakhleh","year":"2016","journal-title":"Hormones (Athens)"},{"issue":"2 Pt 2","key":"10.1016\/j.ncl.2018.09.009_bib68","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/AOG.0b013e31829e398a","article-title":"Cabergoline therapy for Cushing\u2019s disease throughout pregnancy","volume":"122","author":"Woo","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ncl.2018.09.009_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejogrb.2012.12.015","article-title":"The medical management of Cushing\u2019s syndrome during pregnancy","volume":"168","author":"Lim","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ncl.2018.09.009_bib70","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1210\/jc.2007-2734","article-title":"Treatment of adrenocorticotropin dependent Cushing\u2019s syndrome: a consensus statement","volume":"93","author":"Biller","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ncl.2018.09.009_bib71","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1210\/jc.2012-3362","article-title":"National incidence and prevalence of TSH-secreting pituitary adenomas in Sweden","volume":"98","author":"Onnestam","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ncl.2018.09.009_bib72","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.beem.2009.05.006","article-title":"TSH-secreting adenomas","volume":"23","author":"Beck-Peccoz","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.ncl.2018.09.009_bib73","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000351007","article-title":"European thyroid association guidelines for the diagnosis and treatment of thyrotropin-secreting pituitary","volume":"2","author":"Beck-Peccoz","year":"2013","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.ncl.2018.09.009_bib74","doi-asserted-by":"crossref","first-page":"R183","DOI":"10.1530\/EJE-16-1029","article-title":"Diagnosis of endocrine disease. Diagnostic approach to TSH-producing pituitary adenoma","volume":"177","author":"Tj\u00f6rnstrand","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.ncl.2018.09.009_bib75","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1210\/jc.2013-4376","article-title":"Thyrotropin-secreting pituitary adenomas: outcome of pituitary surgery and irradiation","volume":"99","author":"Malchiodi","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ncl.2018.09.009_bib76","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1089\/thy.2016.0457","article-title":"2017 guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum","volume":"27","author":"Alexander","year":"2017","journal-title":"Thyroid"},{"issue":"4","key":"10.1016\/j.ncl.2018.09.009_bib77","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3803\/EnM.2015.30.4.443","article-title":"Diagnosis and treatment of hypopituitarism","volume":"30","author":"Kim","year":"2015","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"11","key":"10.1016\/j.ncl.2018.09.009_bib78","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1210\/jc.2016-2118","article-title":"Hormonal replacement in hypopituitarism in adults: an Endocrine Society Clinical Practice Guideline","volume":"101","author":"Fleseriu","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ncl.2018.09.009_bib79","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.wneu.2016.04.059","article-title":"A\u00a0benchmark for preservation of normal pituitary function after endoscopic transsphenoidal surgery for pituitary macroadenomas","volume":"91","author":"Laws","year":"2016","journal-title":"World Neurosurg"},{"issue":"Suppl 1","key":"10.1016\/j.ncl.2018.09.009_bib80","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1111\/pme.12926","article-title":"Opioid related endocrinopathy","volume":"16","author":"Gudin","year":"2015","journal-title":"Pain Med"},{"issue":"7","key":"10.1016\/j.ncl.2018.09.009_bib81","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.mayocp.2018.04.010","article-title":"Opioid-induced adrenal insufficiency","volume":"93","author":"Donegan","year":"2018","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.ncl.2018.09.009_bib82","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/cen.13063","article-title":"Immune checkpoint inhibitor-related hypophysitis and endocrine dysfunction: clinical review","volume":"85","author":"Joshi","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ncl.2018.09.009_bib83","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa040079","article-title":"Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism","volume":"351","author":"Alexander","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ncl.2018.09.009_bib84","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4158\/EP.2.5.353","article-title":"Diagnosis and management of diabetes insipidus during pregnancy","volume":"2","author":"Durr","year":"1996","journal-title":"Endocr Pract"},{"issue":"6","key":"10.1016\/j.ncl.2018.09.009_bib85","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1210\/jc.2011-0179","article-title":"Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"Molitch","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ncl.2018.09.009_bib86","doi-asserted-by":"crossref","first-page":"R47","DOI":"10.1530\/EJE-18-0306","article-title":"Therapy of endocrine disease: growth hormone replacement therapy in adults: 30 years of personal clinical experience","volume":"179","author":"Jorgensen","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.ncl.2018.09.009_bib87","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1046\/j.1365-2265.2002.01572.x","article-title":"Growth hormone (GH) replacement therapy in GH-deficient women during pregnancy","volume":"57","author":"Wiren","year":"2002","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ncl.2018.09.009_bib88","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1530\/eje.0.1390054","article-title":"Is maternal growth hormone essential for a normal pregnancy?","volume":"139","author":"Curran","year":"1998","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ncl.2018.09.009_bib89","doi-asserted-by":"crossref","first-page":"E572","DOI":"10.1152\/ajpendo.1993.265.4.E572","article-title":"Regulation of maternal IGF-I by placental GH in normal and abnormal pregnancies","volume":"265","author":"Caufriez","year":"1993","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ncl.2018.09.009_bib90","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1067\/mob.2003.82","article-title":"Increase in maternal placental growth hormone during pregnancy and disappearance during parturition in normal and growth hormone deficient pregnancies","volume":"188","author":"Lonberg","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ncl.2018.09.009_bib91","doi-asserted-by":"crossref","first-page":"16092","DOI":"10.1038\/nrdp.2016.92","article-title":"Sheehan syndrome","volume":"2","author":"Karaca","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"10.1016\/j.ncl.2018.09.009_bib92","first-page":"190","article-title":"A\u00a0primer on pituitary injury for the obstetrician gynecologist: Simmond\u2019s disease, Sheehan\u2019s syndrome, traumatic injury, Dahan\u2019s syndrome, pituitary apopolexy and lymphocytic hypophysitis","volume":"69","author":"Dahan","year":"2017","journal-title":"Minerva Ginecologica"},{"key":"10.1016\/j.ncl.2018.09.009_bib93","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s11102-010-0276-x","article-title":"Analysis of thrombophilic genetic mutations in patients with Sheehan\u2019s syndrome: is thrombophilia responsible for the pathogenesis of Sheehan\u2019s syndrome?","volume":"14","author":"Gokalp","year":"2011","journal-title":"Pituitary"},{"key":"10.1016\/j.ncl.2018.09.009_bib94","first-page":"150001","article-title":"Pituitary injury and persistent hypofunction resulting from a peripartum non-hemorrhagic, vaso-occlusive event","volume":"2015","author":"Kuriya","year":"2015","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"10.1016\/j.ncl.2018.09.009_bib95","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1210\/jc.2001-020242","article-title":"Pituitary autoimmunity in patients with Sheehan\u2019s syndrome","volume":"87","author":"Goswami","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ncl.2018.09.009_bib96","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s11102-012-0405-9","article-title":"Lymphocyte subpopulations in Sheehan\u2019s syndrome","volume":"16","author":"Atmaca","year":"2013","journal-title":"Pituitary"},{"key":"10.1016\/j.ncl.2018.09.009_bib97","doi-asserted-by":"crossref","first-page":"8415860","DOI":"10.1155\/2018\/8415860","article-title":"Sheehan's syndrome revisited: underlying autoimmunity or hypoperfusion?","volume":"2018","author":"Gonz\u00e1lez-Gonz\u00e1lez","year":"2018","journal-title":"Int J Endocrinol"},{"issue":"1","key":"10.1016\/j.ncl.2018.09.009_bib98","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12884-017-1380-y","article-title":"A\u00a0case of acute Sheehan's syndrome and literature review: a rare but life-threatening complication of postpartum hemorrhage","volume":"17","author":"Matsuzaki","year":"2017","journal-title":"BMC Pregnancy Childbirth"},{"issue":"3","key":"10.1016\/j.ncl.2018.09.009_bib99","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1530\/EJE-14-0244","article-title":"Extensive investigation of 114 patients with Sheehan\u2019s syndrome: a continuing disorder","volume":"171","author":"Diri","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ncl.2018.09.009_bib100","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40842-016-0034-8","article-title":"Hypophysitis: evaluation and management","volume":"2","author":"Faje","year":"2016","journal-title":"Clin Diabetes Endocrinol"},{"issue":"5","key":"10.1016\/j.ncl.2018.09.009_bib101","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1210\/er.2004-0011","article-title":"Autoimmune hypophysitis","volume":"26","author":"Caturegli","year":"2005","journal-title":"Endocr Rev"},{"issue":"2","key":"10.1016\/j.ncl.2018.09.009_bib102","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s11102-016-0769-3","article-title":"Lymphocytic hypophysitisis: modern day management with limited role for surgery","volume":"20","author":"Kyriacou","year":"2017","journal-title":"Pituitary"},{"issue":"Suppl 5","key":"10.1016\/j.ncl.2018.09.009_bib103","first-page":"145","article-title":"Lymphocytic hypophysitis","volume":"68","author":"Molitch","year":"2007","journal-title":"Horm Res"},{"issue":"4","key":"10.1016\/j.ncl.2018.09.009_bib104","doi-asserted-by":"crossref","first-page":"447","DOI":"10.4158\/EP15985.OR","article-title":"Variations in clinical and imaging findings by time of diagnosis in females with hypopituitarism attributed to lymphocytic hypophysitis","volume":"22","author":"Tirosh","year":"2016","journal-title":"Endocr Pract"},{"key":"10.1016\/j.ncl.2018.09.009_bib105","doi-asserted-by":"crossref","DOI":"10.1007\/s11102-018-0892-4","article-title":"Neuro-radiological features can predict hypopituitarism in primary autoimmune hypophysitis","author":"Tartaglione","year":"2018","journal-title":"Pituitary"},{"key":"10.1016\/j.ncl.2018.09.009_bib106","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000452905","article-title":"Pituitary autoimmunity","volume":"48","author":"Guaraldi","year":"2017","journal-title":"Front Horm Res"},{"issue":"10","key":"10.1016\/j.ncl.2018.09.009_bib107","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1210\/jc.2018-01021","article-title":"Hypophysitis outcome and factors predicting responsiveness to glucocorticoid therapy: a prospective and double-arm study","volume":"103","author":"Chiloiro","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.ncl.2018.09.009_bib108","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1210\/jc.2015-2146","article-title":"Treatment of primary hypophysitis in Germany","volume":"100","author":"Honegger","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861918312581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861918312581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:16:59Z","timestamp":1760005019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861918312581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":108,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0733861918312581"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2018.09.009","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pituitary Disorders in Pregnancy","name":"articletitle","label":"Article Title"},{"value":"Neurologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncl.2018.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}